Bethkis and Valacyclovir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Bethkis (tobramycin) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include cystic fibrosis among females and cystic fibrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Bethkis and Valacyclovir. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Bethkis?
Bethkis has active ingredients of tobramycin. eHealthMe is studying from 2,409 Bethkis users. Check the latest studies of Bethkis.
What is Valacyclovir?
Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.
11 people who take Bethkis and Valacyclovir together, and have interactions are studied.
What are the common drug interactions of Bethkis and Valacyclovir, by gender? *:
female:
- Cystic fibrosis (disease of the secretary glands)
- Drug ineffective
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
male:
- Cystic fibrosis (disease of the secretary glands)
- Chronic kidney disease
- Lung transplant rejection (failure of lung transplant)
- Obliterative bronchiolitis (bronchiolar inflammation)
What are the common drug interactions of Bethkis and Valacyclovir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
40-49:
- Cystic fibrosis (disease of the secretary glands)
50-59:
n/a
60+:
- Drug ineffective
What are the existing conditions these people have? *
- Cystic Fibrosis (disease of the secretary glands): 7 people, 63.64%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 4 people, 36.36%
- Pain: 2 people, 18.18%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
- Nausea (feeling of having an urge to vomit): 1 person, 9.09%
- Dyspnea (difficult or laboured breathing): 1 person, 9.09%
- Cough: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Bethkis and Valacyclovir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Bethkis (2,409 reports)
- Valacyclovir (42,107 reports)
Browse all drug interactions of Bethkis and Valacyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bethkis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valacyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bethkis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valacyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on tobramycin and valacyclovir hydrochloride (the active ingredients of Bethkis and Valacyclovir, respectively), and Bethkis and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Hydrocortisone and Selenium - 2 seconds ago
- Drug interactions of Paroxetine Hydrochloride and Oxcarbazepine - 17 seconds ago
- Could Valium cause Thrombophlebitis Superficial? - 23 seconds ago
- Could Zejula cause Lower Limb Fracture? - 29 seconds ago
- Could Levetiracetam cause Anticonvulsant Drug Level Decreased? - 31 seconds ago
- Drug interactions of Zinacef and Cymbalta - 44 seconds ago
- Could Bupropion Hydrobromide cause Asthma? - 54 seconds ago
- Could Bupropion Hydrobromide cause Burning Sensation? - 59 seconds ago
- Could Bupropion Hydrobromide cause Nasal Congestion? - a minute ago
- Could Protonix cause Cognitive Disorder? - a minute ago